Almirall, Novo Nordisk Reach Licensing Agreement Surrounding IL-21 Blocking Monoclonal Antibodies
Image Credit: Adobe Stock Images/PeterSchreiber.media.com Almirall S.A., a dermatology-focused pharmaceutical company, has entered into an exclusive license agreement with Novo…
